New product intros (apalutamide, betrixaban, bictegravir/emtricitabine/tenofovir alafenamide fumarate (new combination), ertugliflozin, ertugliflozin/metformin hydrochloride (new combination), ertugliflozin/sitagliptin (new combination), nonacog beta pegol, plecanatide (new indication), semaglutide, synthetic human angiotensin II, tezacaftor/ivacaftor (new combination))

2018 ◽  
Vol 54 (2) ◽  
pp. 177
Sign in / Sign up

Export Citation Format

Share Document